DOI: 10.1055/s-00000020

Geburtshilfe und Frauenheilkunde

References

Litton JK, Scoggins M, Hess KR. et al.
Neoadjuvant talazoparib (TALA) for operable breast cancer patients with a BRCA mutation (BRCA+).

J Clin Oncol 2018;
36 (Suppl.) Abstr.. 508

Download Bibliographical Data

Search in: